Login / Signup

What is the risk of cardiovascular events in osteoporotic patients treated with romosozumab?

Ian R Reid
Published in: Expert opinion on drug safety (2022)
Keyphrases
  • cardiovascular events
  • bone mineral density
  • coronary artery disease
  • cardiovascular disease
  • postmenopausal women
  • body composition